ZVRA Zevra Therapeutics, Inc.

$12.01▼ -0.41% Healthcare Other
After hours $11.95▼ -0.50% Sep 11, 7:30 PM ET
Volume 579.4K Avg Volume (10D) 910.2K
Key Metrics & Fundamentals
Market Cap
$713.20M
P/E Ratio
12.9
Div Yield
–%
52W Range
7.16 - 15.04
% vs 50 MA
0.90%
% vs 200 MA
16.08%
RSI-14
51.6
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.85
Free Cash Flow
$16.82M
Gross Rev
$39.66M
Gross Profit
$38.14M
EBITDA
$19.71M
COGS
$1.53M
Operating Exp
$21.36M
Operating Income
$16.78M
EBIT
$16.78M
Pretax Income
$12.79M
Net Income
$8.75M
EPS (Diluted)
0.14
Price & Volume History
Loading chart…
Recent News
Zevra Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 11:30 AM
Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium
GlobeNewswire · Aug 25, 2026 11:30 AM
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 21, 2026 8:30 PM
Zevra Therapeutics Insider Sold Shares Worth $474,774, According to a Recent SEC Filing
MT Newswires · Aug 17, 2026 8:38 PM
What Could Zevra Therapeutics (ZVRA) New NPC Data Mean For Its Europe Review?
Simply Wall St. · Aug 7, 2026 5:12 AM
Zevra Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 8:04 AM
Zevra Therapeutics Inc (ZVRA) (Q2 2026) Earnings Call Highlights: Revenue Surges 53% as ...
GuruFocus.com · Aug 6, 2026 5:08 AM
Zevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates
Zacks · Aug 6, 2026 12:35 AM
Zevra Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 9:15 PM
Zevra Reports Second Quarter 2026 Financial Results and Corporate Update
GlobeNewswire · Aug 5, 2026 8:05 PM
Financial Overview - Income Statement Quarterly

See ZVRA's money flow as a full page

Social Sentiment
Avg +0.83 · 3 posts
DDNewsTradeDiscussionZVRA DD/YOLO ~$70k (5,000 Shares + Jan 10 Calls)
r/wallstreetbets · Oct 13, 2025
The post expresses strong bullish sentiment towards ZVRA, highlighting revenue growth, cash reserves, and potential for EU approval.
very_positive +0.90
NewsDiscussionDDMAKE SOME MONEY AND HELP A SMALL BIOTECH COMPANY THAT BEING MANIPULATED
r/wallstreetbets · Sep 15, 2024
The post is enthusiastic about ZVRA's prospects and PDUFA date, highlighting key positive information.
positive +0.80
DDTradeUnderrated post of the year. Extensive DD on ZVRA. Full disclosure, I'm all in on ZVRA, up 55% and holding for the cake, not these crumbs
r/wallstreetbets · Sep 13, 2024
The author is bullish, stating they are 'all in' and up 55%, indicating strong confidence.
positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙